RCT of a Polyherbal Dietary Supplement for Prediabetes
Public ClinicalTrials.gov record NCT03388762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo-controlled Clinical Trial of a Polyherbal Dietary Supplement (GlucoSupreme™ Herbal) on Markers of Glycemic Control Among Prediabetic Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to evaluate the impact of a polyherbal dietary supplement (Designs for Health - GlucoSupreme™ Herbal) on markers of glycemic control and other structure/function outcomes among a sample of prediabetic adults. A 12-week randomized, double-blinded, placebo-controlled clinical trial will be conducted to achieve the purpose of this study. The research team hypothesizes that GlucoSupreme™ Herbal will improve a variety of validated markers of glycemic control that are commonly used in clinical practice more effectively than placebo.
Study identification
- NCT ID
- NCT03388762
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 39 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 4, 2017
- Primary completion
- Sep 29, 2019
- Completion
- Dec 31, 2019
- Last update posted
- Jun 27, 2022
2017 – 2020
United States locations
- U.S. sites
- 4
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Maryland Center for Diabetes and Endocrinology | Baltimore | Maryland | 21201 | — |
| University of Maryland Family Medicine Associates | Baltimore | Maryland | 21201 | — |
| University of Maryland School of Medicine, Department of Family and Community Medicine, East Hall | Baltimore | Maryland | 21201 | — |
| Alliance Integrative Medicine | Cincinnati | Ohio | 45236 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Prediabetic State trials
Other public records listing Prediabetic State. Sorted by last update posted; newest first. Not a recommendation.
- NCT07794579: A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity Not yet recruiting
- NCT07403604: Effect of Insulin Lowering on Lipogenesis Recruiting
- NCT06580964: Heat and Exercise in Aging as Therapy (HEAT) Recruiting
- NCT05835037: Effect of Zinc on Glucose Homeostasis Recruiting
- NCT05351476: Exercise Training and Fat Metabolism in Postmenopausal Women Recruiting
- NCT06354088: Human Models of Selective Insulin Resistance: Alpelisib, Part I Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03388762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 27, 2022 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03388762 live on ClinicalTrials.gov.